EGFR and neoplasm: The significant difference between histological type (with lower PD-L1 scores for AC than SqCC) and between mutational status (EGFR mutation vs. KRAS mutation vs. EGFR/KRAS negative) remained in multiple regression analysis, as seen in Table 2, while there was no difference between cohorts, sample types, or tumor location.